MIDAMOR (amiloride hydrochloride) by Design Pharmaceuticals is clinical pharmacology amiloride hcl is a potassium-conserving (antikaliuretic) drug that possesses weak (compared with thiazide diuretics) natriuretic, diuretic, and antihypertensive activity. Approved for hypertension. First approved in 1981.
Drug data last refreshed 18h ago · AI intelligence enriched 3d ago
MIDAMOR (amiloride HCl) is an oral potassium-conserving diuretic used to treat hypertension, often as an adjunct to thiazide or loop diuretics. It works by inhibiting sodium reabsorption in the distal convoluted tubule and collecting duct, reducing potassium and hydrogen secretion while maintaining serum potassium levels. The drug has weak natriuretic and diuretic effects compared to thiazides but provides significant electrolyte-sparing benefits.
Product approaching loss of exclusivity with moderate competitive pressure (30/100); brand team likely focused on retention strategies and limited growth initiatives.
CLINICAL PHARMACOLOGY Amiloride HCl is a potassium-conserving (antikaliuretic) drug that possesses weak (compared with thiazide diuretics) natriuretic, diuretic, and antihypertensive activity. These effects have been partially additive to the effects of thiazide diuretics in some clinical studies.…
Worked on MIDAMOR at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Bioequivalence Study Between GSK3542503 Hydrochlorothiazide + Amiloride Hydrochloride 50 mg: 5 mg Tablets and Reference Product in Healthy Adult Participants Under Fasting Conditions
MIDAMOR offers limited career growth due to its mature, off-patent status and narrow indication as an adjunctive therapy. Roles on this product are primarily defensive and operational, focused on maintaining market share against newer competitors rather than driving innovation or expansion.